A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters New trial data suggests Novo Nordisk‘s weight loss drug Wegovy edges out rival treatments on heart condition risk reduction, in good news for the Danish pharma giant as it…
LONDON — Shares of Danish pharmaceutical giant Novo Nordisk were 3% higher in early deals Monday, after the company released trial data suggesting its blockbuster drug Wegovy outperforms major rivals in heart disease risk reduction. The study found continued users of semaglutide, a weight management drug branded as Wegovy, had up to a 57% greater reduction…
My top 10 things to watch Thursday, Aug. 28 1. Nvidia is accelerating when others say slowing. Beat and raise quarter . Who is right, the company or the critics who want you to trade it, not own it? The concept of “long-thinking” driving compute demand. New verticals galore. Core growth is extraordinary. On the…
My top 10 things to watch Wednesday, Aug. 27 1. It’s Nvidia day. In a preview for Club members, we outlined four burning questions for tonight’s call, including what’s happening with orders for the newest Blackwell chip, the GB300, and details on the total cost of ownership for its market-leading tech. China and margins also in…
The stock market has been on a wild march higher this year — driven by the White House’s shifting trade policy, geopolitical concerns, and conflicting economic data. The barrage of headlines — both positive and negative — is creating an intimidating backdrop. The good news? The way to value stocks stays the same, no matter…
The Club’s 10 things to watch Wednesday, Aug. 20 — Today’s newsletter was written by Investing Club editor Kevin Stankiewicz. 1. Wall Street was set to open slightly lower today after the S & P 500 closed lower yesterday for the third session in a row. Investors were parsing the latest retail earnings this morning….
The Club’s 10 things to watch Tuesday, Aug. 19 1. Club name Palo Alto Networks answered the bell with its quarterly results and guidance, sending shares up 6% this morning. The numbers make it clear that Palo Alto’s blockbuster CyberArk acquisition was made from a position of strength , not weakness in its core business….
The Club’s 10 things to watch Monday, Aug. 18 — Today’s newsletter was written by Zev Fima, the Club’s portfolio analyst. 1. Stocks are poised to start the week a bit lower. Crypto is continuing to sell off, and the yield on the 10-year Treasury note is down slightly to 4.295%. Oil and gold slightly…
The stock market ended the week higher as Wall Street speculated on how a spate of economic releases would impact the Federal Reserve’s next interest rate decision. The S & P 500 and Nasdaq both gained nearly 1% over the past five sessions. Both benchmark gauges hit several record closes this week, with the S…
The stock market has been on a tear over the past month, as Wall Street mulled over quarterly earnings reports, President Donald Trump ‘s tariff moves, and the Federal Reserve’s next monetary policy decision. Since last month’s third annual meeting of the CNBC Investing Club, the S & P 500 and Nasdaq hit nine and…